Adventitious agent safety of urine-derived medicinal products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/BWP/126802/2012
Effective from01/12/2015
KeywordsUrine-derived medicinal products, adventitious agents, investigational studies
DescriptionThis document considers various aspects of viral saefty of urine-derived medicinal products: it provides guidance in inactivation/removal of virus and its validation.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

In operation: 01/12/2015–present

Published: 29/05/2015

Published: 22/11/2013

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more